People in the News: Urmi Prasad Richardson

May 14, 2014

Premium

Foundation Medicine has appointed Urmi Prasad Richardson to vice president of its international business to lead international commercialization efforts. Richardson will be based in Germany. Previously, she held leadership positions at Chiron, Novartis, and Immucor.

Filed under

Clinical Sequencing

Sequencing

Diagnostics

Next-Generation Sequencing

People in the News: Urmi Prasad Richardson

Filed under

New Products Posted to GenomeWeb: MagBio Genomics, Golden Helix, Qiagen, NeoGenomics, More

People in the News at Phase Genomics, QuidelOrtho, Inflammatix, CareDx

In Brief This Week: Bruker, Qiagen, Prenetics, CellChorus, T2 Biosystems, More

MiLaboratories Raises $10M in Series A, Launches Genomic Data Analysis Platform

Pacific Biosciences, National Cancer Center of Singapore to Sequence Cancers Prevalent in Asia

Illumina Launches Push-Button Sequencing With New Low-Throughput MiSeq i100 Line
Premium

Foundation Medicine Test Approved by FDA as CDx for Itovebi in Breast Cancer Patients

Variantyx Combines Long Nanopore, Short Illumina Reads for Rare Disease Whole-Genome Diagnostic Test
Premium

Studies of Chinese Pregnancies Delve Into Underlying Genetic Contributors to Diseases and Conditions

Pacific Biosciences, National Cancer Center of Singapore to Sequence Cancers Prevalent in Asia

People in the News: Urmi Prasad Richardson

Filed under

Illumina Launches Push-Button Sequencing With New Low-Throughput MiSeq i100 Line Premium

Variantyx Combines Long Nanopore, Short Illumina Reads for Rare Disease Whole-Genome Diagnostic Test Premium

Illumina Launches Push-Button Sequencing With New Low-Throughput MiSeq i100 Line
Premium

Variantyx Combines Long Nanopore, Short Illumina Reads for Rare Disease Whole-Genome Diagnostic Test
Premium